Thus, miR-199a downregulation reversed the pathological phenotypes caused by MeCP2 overexpression, indicating that miR-199a plays a critical functional role downstream of MeCP2 in the pathophysiology of MDS. Here, MECP2 is linked to myelodysplastic syndrome.